Showing 1 - 16 results of 16 for search 'A Louis Bourgeois', query time: 0.06s Refine Results
  1. 1
    Oral inactivated whole cell vaccine for mucosal immunization: ETVAX case study

    Oral inactivated whole cell vaccine for mucosal immunization: ETVAX case study by Richard I. Walker, A. Louis Bourgeois

    Published 2023-03-01
    Get full text
    Article
  2. 2
    Special Issue on Enterotoxigenic <i>Escherichia coli</i> (ETEC) Vaccines: ETEC Infection and Vaccine-Mediated Immunity

    Special Issue on Enterotoxigenic <i>Escherichia coli</i> (ETEC) Vaccines: ETEC Infection and Vaccine-Mediated Immunity by Frederick J Cassels, Ibrahim Khalil, A. Louis Bourgeois, Richard I Walker

    Published 2024-05-01
    Get full text
    Article
  3. 3
    Intestinal and systemic inflammation induced by symptomatic and asymptomatic enterotoxigenic E. coli infection and impact on intestinal colonization and ETEC specific immune responses in an experimental human challenge model

    Intestinal and systemic inflammation induced by symptomatic and asymptomatic enterotoxigenic E. coli infection and impact on intestinal colonization and ETEC specific immune respon... by Jessica Brubaker, Xueyan Zhang, A. Louis Bourgeois, Clayton Harro, David A Sack, Subhra Chakraborty

    Published 2021-01-01
    Get full text
    Article
  4. 4
    Adjuvant effect of enterotoxigenic Escherichia coli (ETEC) double-mutant heat-labile toxin (dmLT) on systemic immunogenicity induced by the CFA/I/II/IV MEFA ETEC vaccine: Dose-related enhancement of antibody responses to seven ETEC adhesins (CFA/I, CS1-CS6)

    Adjuvant effect of enterotoxigenic Escherichia coli (ETEC) double-mutant heat-labile toxin (dmLT) on systemic immunogenicity induced by the CFA/I/II/IV MEFA ETEC vaccine: Dose-rela... by Hyesuk Seo, Ti Lu, Sachin Mani, A. Louis Bourgeois, Richard Walker, David A. Sack, Weiping Zhang

    Published 2020-02-01
    Get full text
    Article
  5. 5
    <i>Shigella</i> -Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei

    <i>Shigella</i> -Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei by Kristen A. Clarkson, Chad K. Porter, Kawsar R. Talaat, Robert W. Frenck, Cristina Alaimo, Patricia Martin, A. Louis Bourgeois, Robert W. Kaminski

    Published 2021-08-01
    Get full text
    Article
  6. 6
    Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice.

    Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice. by Milton Maciel, Mark Smith, Steven T Poole, Renee M Laird, Julianne E Rollenhagen, Robert W Kaminski, Heather Wenzel, A Louis Bourgeois, Stephen J Savarino

    Published 2019-01-01
    Get full text
    Article
  7. 7
    Linking inherent O-Linked Protein Glycosylation of YghJ to Increased Antigen Potential

    Linking inherent O-Linked Protein Glycosylation of YghJ to Increased Antigen Potential by Mette Thorsing, Thøger Jensen Krogh, Lars Vitved, Arkadiusz Nawrocki, Rikke Jakobsen, Martin R. Larsen, Subhra Chakraborty, A. Louis Bourgeois, Ann Zahle Andersen, Anders Boysen

    Published 2021-08-01
    Get full text
    Article
  8. 8
    Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers.

    Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers. by Subhra Chakraborty, Clayton Harro, Barbara DeNearing, Jessica Brubaker, Sean Connor, Nicole Maier, Len Dally, Jorge Flores, A Louis Bourgeois, Richard Walker, David A Sack

    Published 2018-04-01
    Get full text
    Article
  9. 9
    Safety and immunogenicity in humans of enterotoxigenic Escherichia coli double mutant heat-labile toxin administered intradermally

    Safety and immunogenicity in humans of enterotoxigenic Escherichia coli double mutant heat-labile toxin administered intradermally by Marcela F. Pasetti, Patricia L. Milletich, Jessica A. White, Jessica Butts, Rebecca C. Brady, Michelle D. Dickey, Cassandra Ballou, Nicole Maier, Marcelo B. Sztein, Shahida Baqar, A. Louis Bourgeois, David I. Bernstein

    Published 2025-02-01
    Get full text
    Article
  10. 10
    Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score.

    Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score. by Chad K Porter, Amanda Lynen, Mark S Riddle, Kawsar Talaat, David Sack, Ramiro L Gutiérrez, Robin McKenzie, Barbara DeNearing, Brittany Feijoo, Robert W Kaminski, David N Taylor, Beth D Kirkpatrick, A Louis Bourgeois

    Published 2018-01-01
    Get full text
    Article
  11. 11
    Efficacy of an Enterotoxigenic <i>Escherichia coli</i> (ETEC) Vaccine on the Incidence and Severity of Traveler’s Diarrhea (TD): Evaluation of Alternative Endpoints and a TD Severity Score

    Efficacy of an Enterotoxigenic <i>Escherichia coli</i> (ETEC) Vaccine on the Incidence and Severity of Traveler’s Diarrhea (TD): Evaluation of Alternative Endpoints and a TD Severi... by Nicole Maier, Shannon L. Grahek, Jane Halpern, Suzanne Restrepo, Felipe Troncoso, Janet Shimko, Olga Torres, Jaime Belkind-Gerson, David A. Sack, Ann-Mari Svennerholm, Björn Gustafsson, Björn Sjöstrand, Nils Carlin, A. Louis Bourgeois, Chad K. Porter

    Published 2023-09-01
    Get full text
    Article
  12. 12
    An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli.

    An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli. by Chad K Porter, Mark S Riddle, Ashley N Alcala, David A Sack, Clayton Harro, Subhra Chakraborty, Ramiro L Gutierrez, Stephen J Savarino, Michael Darsley, Robin McKenzie, Barbara DeNearing, Hans Steinsland, David R Tribble, A Louis Bourgeois

    Published 2016-01-01
    Get full text
    Article
  13. 13
    Validation of a Human Challenge Model Using an LT-Expressing Enterotoxigenic <i>E. coli</i> Strain (LSN03-016011) and Characterization of Potential Amelioration of Disease by an Investigational Oral Vaccine Candidate (VLA1701)

    Validation of a Human Challenge Model Using an LT-Expressing Enterotoxigenic <i>E. coli</i> Strain (LSN03-016011) and Characterization of Potential Amelioration of Disease by an In... by Kawsar R. Talaat, Chad K. Porter, Subhra Chakraborty, Brittany L. Feijoo, Jessica Brubaker, Brittany M. Adjoodani, Barbara DeNearing, Michael G. Prouty, Steven T. Poole, A. Louis Bourgeois, Madison Billingsley, David A. Sack, Susanne Eder-Lingelbach, Christian Taucher

    Published 2024-04-01
    Get full text
    Article
  14. 14
    Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trial.

    Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trial. by Kawsar R Talaat, Chad K Porter, Kayla M Jaep, Christopher A Duplessis, Ramiro L Gutierrez, Milton Maciel, Brittany Adjoodani, Brittany Feijoo, Subhra Chakraborty, Jessica Brubaker, Stefanie A Trop, Mark S Riddle, Sabrina S Joseph, A Louis Bourgeois, Michael G Prouty

    Published 2020-01-01
    Get full text
    Article
  15. 15
    Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection

    Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection by Kawsar R. Talaat, Cristina Alaimo, Patricia Martin, A. Louis Bourgeois, Anita M. Dreyer, Robert W. Kaminski, Chad K. Porter, Subhra Chakraborty, Kristen A. Clarkson, Jessica Brubaker, Daniel Elwood, Rahel Frölich, Barbara DeNearing, Hailey Weerts, Brittany L. Feijoo, Jane Halpern, David Sack, Mark S. Riddle, Veronica Gambillara Fonck

    Published 2021-04-01
    Get full text
    Article
  16. 16
    Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine

    Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine by Kristen A. Clarkson, Kawsar R. Talaat, Cristina Alaimo, Patricia Martin, A. Louis Bourgeois, Anita Dreyer, Chad K. Porter, Subhra Chakraborty, Jessica Brubaker, Daniel Elwood, Rahel Frölich, Barbara DeNearing, Hailey P. Weerts, Brittany Feijoo, Jane Halpern, David Sack, Mark S. Riddle, Veronica Gambillara Fonck, Robert W. Kaminski

    Published 2021-04-01
    Get full text
    Article

Search Tools: